SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001520138-19-000143
Filing Date
2019-05-10
Accepted
2019-05-10 15:25:40
Documents
41
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR PERIOD ENDING MARCH 31, 2019 bivi-20190331_10q.htm 10-Q 353115
2 EXHIBIT 31.1 bivi-20190331_10qex31z1.htm EX-31.1 12519
3 EXHIBIT 31.2 bivi-20190331_10qex31z2.htm EX-31.2 12180
4 EXHIBIT 32.1 bivi-20190331_10qex32z1.htm EX-32.1 5314
5 EXHIBIT 32.2 bivi-20190331_10qex32z2.htm EX-32.2 5531
  Complete submission text file 0001520138-19-000143.txt   1920796

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE bivi-20190331.xml EX-101.INS 322612
7 XBRL CALCULATION FILE bivi-20190331_cal.xml EX-101.CAL 29961
8 XBRL DEFINITION FILE bivi-20190331_def.xml EX-101.DEF 61821
9 XBRL LABEL FILE bivi-20190331_lab.xml EX-101.LAB 182655
10 XBRL PRESENTATION FILE bivi-20190331_pre.xml EX-101.PRE 127503
11 XBRL SCHEMA FILE bivi-20190331.xsd EX-101.SCH 23290
Mailing Address 11601 WILSHIRE BLVD. SUITE 1100 LOS ANGELES CA 90025
Business Address 11601 WILSHIRE BLVD. SUITE 1100 LOS ANGELES CA 90025 312-283-5793
BIOVIE INC. (Filer) CIK: 0001580149 (see all company filings)

IRS No.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-55292 | Film No.: 19814608
SIC: 2834 Pharmaceutical Preparations